An investigation for investors in BeiGene, Ltd. (NASDAQ: BGNE) shares over potential securities laws violations by BeiGene, Ltd. was announced.
San Diego, CA -- (SBWIRE) -- 09/24/2019 -- An investigation was announced on behalf of investors of BeiGene, Ltd. (NASDAQ: BGNE) shares over potential securities laws violations by BeiGene, Ltd.
Investors who purchased shares of BeiGene, Ltd. (NASDAQ: BGNE), have certain options and should contact the Shareholders Foundation at email@example.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by BeiGene, Ltd. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
China based BeiGene, Ltd., a commercial-stage biotechnology company, develops and commercializes molecularly-targeted and immuno-oncology drugs for the treatment of cancer in the People's Republic of China, the United States, and internationaly.
On September 5, 2019, a report was published concerning BeiGene, Ltd. The report asserted, inter alia, that BeiGene "is faking sales in order to persuade investors that it can develop a successful platform in China" and that "management may also be skimming R&D and capital budgets."
Shares of BeiGene, Ltd. (NASDAQ: BGNE) declined to as low as $118.00 per share on September 6, 2019.
Those who purchased shares of BeiGene, Ltd. (NASDAQ: BGNE) have certain options and should contact the Shareholders Foundation.
Shareholders Foundation, Inc.
3111 Camino Del Rio North - Suite 423
92108 San Diego
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in conftact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
For more information on this press release visit:
Media Relations Contact
Email: Click to Email Michael Daniels